Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H21FN2O |
| Molecular Weight | 360.4249 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C(CCF)CCn1c2ccccc2nc1C(=O)c3cccc4ccccc43
InChI
InChIKey=KUESSZMROAFKQJ-UHFFFAOYSA-N
InChI=1S/C23H21FN2O/c24-15-6-1-7-16-26-21-14-5-4-13-20(21)25-23(26)22(27)19-12-8-10-17-9-2-3-11-18(17)19/h2-5,8-14H,1,6-7,15-16H2
| Molecular Formula | C23H21FN2O |
| Molecular Weight | 360.4249 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. | 2015 Sep |
|
| Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes. | 2016 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 09:21:06 UTC 2021
by
admin
on
Sat Jun 26 09:21:06 UTC 2021
|
| Record UNII |
U96GD9R3UZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
124519316
Created by
admin on Sat Jun 26 09:21:06 UTC 2021 , Edited by admin on Sat Jun 26 09:21:06 UTC 2021
|
PRIMARY | |||
|
U96GD9R3UZ
Created by
admin on Sat Jun 26 09:21:06 UTC 2021 , Edited by admin on Sat Jun 26 09:21:06 UTC 2021
|
PRIMARY | |||
|
1984789-90-3
Created by
admin on Sat Jun 26 09:21:06 UTC 2021 , Edited by admin on Sat Jun 26 09:21:06 UTC 2021
|
PRIMARY | |||
|
FUBIMINA
Created by
admin on Sat Jun 26 09:21:06 UTC 2021 , Edited by admin on Sat Jun 26 09:21:06 UTC 2021
|
PRIMARY | FUBIMINA (also known as BIM-2201, BZ-2201 and FTHJ) is a synthetic cannabinoid that is the benzimidazole analog of AM-2201 and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside MEPIRAPIM. FUBIMINA acts as a reasonably potent agonist for the CB2 receptor (Ki = 23.45 nM), with 12x selectivity over CB1 (Ki = 296.1 nM), and does not fully substitute for .DELTA.9-THC in rat discrimination studies. Related benzimidazole derivatives have been reported to be highly selective agonists for the CB2 receptor. | ||
|
FUBIMINA
Created by
admin on Sat Jun 26 09:21:06 UTC 2021 , Edited by admin on Sat Jun 26 09:21:06 UTC 2021
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
